TEN people suffering from the ‘mystery disease’ in the Democratic Republic of the Congo tested positive for malaria, a health chief has warned. However, they warned many of the ...
GSK & MMV announce first single-dose medicine for P. vivax malaria, tafenoquine prequalified by WHO and included in WHO guidelines: London, UK Friday, December 6, 2024, 15:00 Hrs ...
Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases, the disease can progress to neurological ...
LONDON, UK I 04, 2024 I GSK plc (LSE/NYSE: GSK) and Medicines for Malaria Venture (MMV) announced today that the World Health Organization (WHO) has ...